Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Novo revamps its direct-to-consumer platform; Roche drug Gazyva approved again

Plus news about Uniquity Bio, Commit Biologics, Rosemont Pharmaceuticals, Aytu and Aclaris Therapeutics. Novo relaunches NovoCare direct-to-consumer platform: Novo is revamping its DTC business with what it calls a "reimagined consumer ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

More from Tuesday 17 November →